title: [Vasovagal syncope. Management with propanthelin bromide].
abstract: OBJECTIVE
  To study propanthelin bromide efficacy in preventing vasovagal syncope relapse.
  
  
  METHODS
  HGZ No. 3 IMSS, Mazatlán, Sinaloa, México, from 1992 to 1995.
  
  
  METHODS
  10 patients with vasovagal syncope were selected from 41 syncope patients.
  
  
  METHODS
  Prospective longitudinal.
  
  
  METHODS
  clinical charts, neurologic and cardiologic evaluation, electrocardiogram, electroencephalogram, C.A.T., Holter, stress test and chest X rays were made. In 10 patients, 15 to 30 mg of propanthelin bromide thrice a day were administered, 12 month survey on was made measured.
  
  
  RESULTS
  Of the 10 patients, 7 were women mean age 18 years. In 9 of them no recurrence was evident abandoned 1 treatment, 4 had side effects.
  
  
  CONCLUSIONS
  Propanthelin bromide decreases vasovagal syncope episodes with few side effects.
authors.affiliation: Hospital General de Zona No. 3., IMSS, Mazatlán, Sinaloa.
authors.forename: C
authors.initials: C
authors.lastname: Corbalá Fuentes
authors.forename: A
authors.initials: A
authors.lastname: Pacheco Ureña
authors.forename: S
authors.initials: S
authors.lastname: Pedraza Ibarra
authors.forename: J A
authors.initials: JA
authors.lastname: Gárate Ureña
authors.forename: L
authors.initials: L
authors.lastname: Manzano Miranda
authors.forename: A
authors.initials: A
authors.lastname: Carrillo Camacho
authors.forename: L
authors.initials: L
authors.lastname: Haro García
mesh_terms: D000293:Adolescent; D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D010276:Parasympatholytics / Q000627:therapeutic use*; D011413:Propantheline / Q000627:therapeutic use*; D011446:Prospective Studies; D019462:Syncope, Vasovagal / Q000188:drug therapy*
chemical_list: D010276:Parasympatholytics; D011413:Propantheline